- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT07571980
The Effects of Low-Flow and Normal-Flow Sevoflurane Anesthesia on Frontal QRS-T Angle and TP-e Interval
The Effects of Low-Flow and Normal-Flow Sevoflurane Anesthesia on Frontal QRS-T Angle and TP-e Interval in Patients Undergoing Elective Laparoscopic Cholecystectomy
Laparoscopic cholecystectomy procedures involve pneumoperitoneum and volatile anesthetics, both of which can significantly influence cardiovascular physiology and autonomic balance. While volatile anesthetics are known to affect myocardial repolarization, the specific impact of Low-Flow Anesthesia (LFA)-a cost-effective and environmentally friendly technique-on these cardiac markers remains under-researched.
This prospective observational study aims to compare the effects of low-flow versus normal-flow sevoflurane anesthesia on two critical non-invasive biomarkers of ventricular repolarization: the Frontal QRS-T angle and the Tp-e interval. These parameters are essential for predicting electrical instability and the risk of malignant arrhythmias. The study will evaluate a total of 128 patients to determine whether different fresh gas flow rates lead to significant changes in cardiac electrophysiological stability during the perioperative and early postoperative periods.
Studie Overzicht
Toestand
Conditie
Interventie / Behandeling
Gedetailleerde beschrijving
This prospective observational study is designed to investigate the electrophysiological effects of different fresh gas flow rates during sevoflurane anesthesia in patients undergoing elective laparoscopic cholecystectomy. Laparoscopic procedures involving pneumoperitoneum and volatile anesthetics are known to influence autonomic nervous system balance and cardiovascular stability. While the impact of inhalation agents on myocardial repolarization is documented, the specific effects of Low-Flow Anesthesia (LFA)-an environmentally and economically favorable technique-on markers of electrical instability remain to be fully elucidated. The primary objective is to evaluate and compare the effects of low-flow and normal-flow sevoflurane techniques on the Frontal QRS-T angle and the Tp-e interval, which serve as critical non-invasive biomarkers for predicting malignant arrhythmia risk and reflecting the transmural distribution of ventricular repolarization.
The study protocol involves 128 patients, a sample size determined by power analysis (80% power, 0.05 alpha) to account for a predicted 35% difference between groups and potential dropouts. Patients are observationally assigned to either the Low-Flow Group (LFG) or the Normal-Flow Group (NFG) according to routine clinical practice. Following a standardized induction and an initial stabilization phase at 4-6 L/min, flow rates are adjusted once the target concentration (MACage +1) is reached: the LFG is reduced to 0.5 L/min, while the NFG is maintained at 2 L/min. Ventilation is managed to keep EtCO2 between 35-45 mmHg. Data collection is performed via high-resolution ECG recordings at four time points: preoperative baseline (T1), 5 minutes post-intubation (T2), 15 minutes post-intubation (T3), and 15 minutes postoperatively (T4).
Another key focus of this research is the detailed analysis of secondary outcomes, including the monitoring of hemodynamic stability (mean arterial pressure and heart rate) across all time points. Furthermore, the study aims to characterize the electrophysiological profile of each technique by analyzing the Tp-e/QT ratio and calculating time-dependent variations in repolarization parameters, specifically the delta changes from baseline to intraoperative stages (ΔT1-T2 and ΔT1-T3). Additionally, a cost-effectiveness analysis will be conducted by determining the total volume of volatile anesthetic consumed in both techniques. Statistical analysis will involve independent samples t-tests for inter-group comparisons, while repeated measures ANOVA with Bonferroni correction will evaluate time-dependent changes. Pearson correlation analysis will be utilized to assess the relationships between continuous variables, providing a comprehensive assessment of the safety and efficacy of low-flow versus normal-flow anesthesia management.
Studietype
Inschrijving (Geschat)
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
- Volwassen
- Oudere volwassene
Accepteert gezonde vrijwilligers
Bemonsteringsmethode
Studie Bevolking
Beschrijving
Inclusion Criteria:
- Patients aged 18 years and older.
- Patients scheduled for elective or semi-elective laparoscopic cholecystectomy.
- Patients who provide written voluntary informed consent.
- Patients with a predicted surgical duration between 60 and 180 minutes.
Exclusion Criteria:
- Patients with heart failure.
- Patients with valvular heart disease or pathology.
- Patients with hemodynamic instability.
- Patients requiring blood transfusion.
- Patients with a preoperative corrected QT (QTc) interval > 450 ms.
- Patients with a known history of cardiac arrhythmia.
- Patients scheduled for emergency surgery.
- Patients with a known risk or family history of malignant hyperthermia.
- Use of medications associated with QT interval prolongation (e.g., ketamine, 5-HT3 antagonists, quetiapine, etc.).
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
Cohorten en interventies
Groep / Cohort |
Interventie / Behandeling |
|---|---|
|
Low-Flow Group (LFG)
Anesthesia induction and initial stabilization (first 6-8 minutes at 4-6 L/min) follow standard hospital protocols.
Fresh Gas Flow (FGF) reduced to 0.5 L/min after the target concentration (MACage +1) is reached.
Ventilation parameters are adjusted to maintain end-tidal carbon dioxide (EtCO2) between 35-45 mmHg with a minimum FiO2 of 0.30.
Volatile anesthetics are discontinued 15 minutes before the estimated end of surgery.
Pre-oxygenation and wash-out are performed at 5-6 L/min with 80% oxygen prior to extubation.
|
Fresh Gas Flow (FGF) reduced to 0.5 L/min after the target concentration (MACage +1) is reached.
|
|
Normal-Flow Group (NFG)
Anesthesia induction and initial stabilization (first 6-8 minutes at 4-6 L/min) follow standard hospital protocols.
Fresh Gas Flow (FGF) maintained at 2 L/min during anesthesia maintenance.
Ventilation parameters are adjusted to maintain end-tidal carbon dioxide (EtCO2) between 35-45 mmHg with a minimum FiO2 of 0.30.
Volatile anesthetics are discontinued 15 minutes before the estimated end of surgery.
Pre-oxygenation and wash-out are performed at 5-6 L/min with 80% oxygen prior to extubation.
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Frontal QRS-T angle
Tijdsspanne: Pre-operative period, 5 minutes after induction, 15 minutes after induction, post operative 15th minute
|
electrocardiogram
|
Pre-operative period, 5 minutes after induction, 15 minutes after induction, post operative 15th minute
|
|
Tp-e interval
Tijdsspanne: Pre-operative period, 5 minutes after induction, 15 minutes after induction, post-operative 15th minute
|
electrocardiogram
|
Pre-operative period, 5 minutes after induction, 15 minutes after induction, post-operative 15th minute
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
blood pressure
Tijdsspanne: during peri-operative period
|
Non-invasive blood pressure (NIBP) monitor
|
during peri-operative period
|
|
heart rate
Tijdsspanne: during peri-operative period
|
electrocardiogram
|
during peri-operative period
|
|
Tp-e/QT ratio
Tijdsspanne: Pre-operative period, 5 minutes after induction, 15 minutes after induction, post-operative 15th minute
|
electrocardiogram
|
Pre-operative period, 5 minutes after induction, 15 minutes after induction, post-operative 15th minute
|
|
Total amount of volatile anesthetic consumed
Tijdsspanne: end of operation
|
Mindray anesthesia machine
|
end of operation
|
|
Total amount of Remifentanil consumed
Tijdsspanne: end of operation
|
infusion pump
|
end of operation
|
Medewerkers en onderzoekers
Sponsor
Publicaties en nuttige links
Algemene publicaties
- Yildirim H, Adanir T, Atay A, Katircioglu K, Savaci S. The effects of sevoflurane, isoflurane and desflurane on QT interval of the ECG. Eur J Anaesthesiol. 2004 Jul;21(7):566-70. doi: 10.1017/s0265021504007112.
- Kim NY, Han DW, Koh JC, Rha KH, Hong JH, Park JM, Kim SY. Effect of Dexmedetomidine on Heart Rate-Corrected QT and Tpeak-Tend Intervals During Robot-Assisted Laparoscopic Prostatectomy With Steep Trendelenburg Position: A Prospective, Randomized, Double-Blinded, Controlled Study. Medicine (Baltimore). 2016 May;95(19):e3645. doi: 10.1097/MD.0000000000003645.
- Bingol Tanriverdi T, Tercan M, Patmano G, Tanriverdi Z, Gusun Halitoglu A, Kaya A. The Effect of Low-Flow and Normal-Flow Desflurane Anesthesia on the Frontal QRS-T Angle in Patients Undergoing Rhinoplasty Operation: A Randomized Prospective Study. Cureus. 2022 Sep 8;14(9):e28920. doi: 10.7759/cureus.28920. eCollection 2022 Sep.
Studie record data
Bestudeer belangrijke data
Studie start (Geschat)
Primaire voltooiing (Geschat)
Studie voltooiing (Geschat)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Aanvullende relevante MeSH-voorwaarden
Andere studie-ID-nummers
- 96-2026
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .